Healthcare Analytical Testing Services Market is expected to generate a revenue of USD 9.56 Billion by 2031, Globally, at 11.20% CAGR: Verified Market Research®
Lewes, Delaware, July 31, 2025 ( GLOBE NEWSWIRE ) -- The Global Healthcare Analytical Testing Services Market Size is projected to grow at a CAGR of 11.20% from 2024 to 2031, according to a new report published by Verified Market Research®.
Labcorp Posts 9.5 Percent Gain in Q2
Laboratory Corporation of America ( NYSE:LH ) , a global leader in diagnostics and drug development, reported results for Q2 2025 on July 24, 2025. The earnings release highlighted strong GAAP revenue growth that beat consensus estimates, adjusted earnings per share ( non-GAAP ) that outpaced ...
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
OPK's growth hinges on RAYALDEE and key partnerships, but rising competition and reliance on one drug pose risks.
Genomics Market to Hit US$66.8 Billion by 2029 with 9.4% CAGR | MarketsandMarkets™.
Delray Beach, FL, June 11, 2025 ( GLOBE NEWSWIRE ) -- The global genomics market, valued at US$42.4 billion in 2023, stood at US$42.6 billion in 2024 and is projected to advance at a resilient CAGR of 9.4% from 2024 to 2029, culminating in a forecasted valuation of US$66.8 billion by the end of ...
Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
Oncocyte Reports Successful 2024. Sets Stage for 2025 Catalysts ...
Organ Transplant Diagnostics Market Size to Surpass USD 12.57 Billion by 2033 | Straits Research
New York, United States, Jan. 29, 2025 ( GLOBE NEWSWIRE ) -- An organ transplant is a surgical procedure replacing a damaged organ with a healthy one. Diagnostics for organ transplants are clinical diagnostic methods that improve the efficacy of transplantation procedures.
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
OPK's growth is fueled by Rayaldee's success and accelerated clinical trials. However, stiff competition and overdependence on its lead product are concerns.
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer - OncoCyte ( NASDAQ:OCX )
Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicine Will provide key regulatory and reimbursement support Will assist business development efforts and strategic partnerships IRVINE, Calif., Jan. 08, 2025 ( GLOBE NEWSWIRE ) -- ...
Healthcare Analytical Testing Services Market to Surpass Valuation of USD 15.55 Billion by 2031 | SkyQuest Technology
Westford, USA, Dec. 15, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the global healthcare analytical testing services market size will reach a value of USD 15.55 Billion by 2031, with a CAGR of 11.2% during the forecast period ( 2024-2031 ) .
Cell-Free DNA Mutation Diagnostics Market to Surge to US$ 81,584.2 Million by 2034, Growing at a CAGR of 24.9% | Fact.MR Report
Rockville, MD , Dec. 05, 2024 ( GLOBE NEWSWIRE ) -- According to Fact.MR, a market research and competitive intelligence provider, the global Cell-free DNA Mutation Diagnostics Market is estimated to reach a valuation of US$ 8,830.4 million in 2024 and is expected to grow at a CAGR of 24.9% ...
Genetic Toxicology Testing Market is Slated to Evolve at a Stellar 12.7% CAGR through 2031 | SkyQuest Technology
Westford, USA, Nov. 28, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that the genetic toxicology testing market size will attain a value of USD 3.84 billion by 2031, with a CAGR of 12.7% over the forecast period ( 2024-2031 ) .
Pharmacovigilance and Drug Safety Software Market Skyrockets to $359.30 Million by 2031 Dominated by Tech Giants - ArisEurope, ICON plc and Syneos Health | The Insight Partners
US & Canada, Nov. 18, 2024 ( GLOBE NEWSWIRE ) -- According to a new comprehensive report from The Insight Partners, the global pharmacovigilance and drug safety software market is observing significant growth owing to surge in drug development spending and cloud-based pharmacovigilance and drug ...
Fortrea Reports Third Quarter 2024 Results
For the three months ended September 30, 2024, from continuing operations: ...
LH Beats on Q3 Earnings, Raises Revenue Guidance Midpoint, Stock Gains
Labcorp beats on earnings and revenues in the third quarter, entering the fourth half of 2024 with robust momentum.
North America Food Testing Market Size & Share to Surpass USD 4.3 billion by 2031, as a CAGR 7.1%: Transparency Market Research, Inc.
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Oct. 21, 2024 ( GLOBE NEWSWIRE ) -- The North America food testing market ( 북미 식품 테스트 시장 ) is estimated to flourish at a CAGR of 7.1% from 2023 to 2031.
Here's Why You Should Retain OPKO Health Stock in Your Portfolio
OPK's growth is fueled by Rayaldee's success and strategic partnerships. However, stiff competition and overdependence on its lead product are concerns.
Clinical Trials Market to Witness 8.7% CAGR by 2031 | SkyQuest Technology
Westford, USA, Sept. 23, 2024 ( GLOBE NEWSWIRE ) -- SkyQuest projects that Clinical Trials Market will attain the value of USD 102.12 Billion by 2031, with a CAGR of 8.7% during the forecast period ( 2024-2031 ) . With the growing middle class and rapid urbanization, people are becoming more ...
Acute Intermittent Porphyria Market Size is Projected to Reach USD 7.1 million by 2034, Growth at CAGR 3.9% | Report by Transparency Market Research, Inc.
Wilmington, Delaware, United States, Transparency Market Research Inc. -, Aug. 27, 2024 ( GLOBE NEWSWIRE ) -- The global acute intermittent porphyria market ( 급성 간헐성 포르피린증 시장 ) is estimated to surge at a CAGR of 3.9% from 2024 to 2034.
Should You Hold Labcorp ( LH ) Stock in Your Portfolio Now?
Labcorp's (LH) slew of partnerships and acquisitions and robust efforts in high-growth areas bode well.
Glenn A Eisenberg Implements A Sell Strategy: Offloads $3.36M In Labcorp Holdings Stock - Labcorp Holdings ( NYSE:LH )
Disclosed on August 19, Glenn A Eisenberg, Chief Financial Officer at Labcorp Holdings LH, executed a substantial insider sell as per the latest SEC filing. What Happened: A Form 4 filing with the U.S.
Fortrea Reports Second Quarter 2024 Results
For the three months ended June 30, 2024, from continuing operations: ...
Labcorp Holdings EVP Trades Company's Stock - Labcorp Holdings ( NYSE:LH )
Making a noteworthy insider sell on August 7, Lance Berberian, EVP at Labcorp Holdings LH, is reported in the latest SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Berberian sold 12,093 shares of Labcorp Holdings.
Labcorp ( LH ) Q2 Earnings Surpass Estimates ( revised )
Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.
Labcorp ( LH ) Q2 Earnings Surpass Estimates, Margins Increase
Labcorp (LH) beats on earnings and revenues in the second quarter, entering the second half of 2024 with robust momentum.
What's in Store for These 4 MedTech Stocks in Q2 Earnings?
Here is a sneak peek into how four MedTech companies, LH, BIO, TFX and BRKR, are expected to fare in their second-quarter results, slated to be released tomorrow.
Here's How Labcorp ( LH ) is Placed Ahead of Q2 Earnings Release
Labcorp's (LH) second-quarter 2024 performance is expected to reflect the robust execution of strategic priorities and solid business performances.
Implied Volatility Surging for Labcorp ( LH ) Stock Options
Investors need to pay close attention to Labcorp (LH) stock based on the movements in the options market lately.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Labcorp ( LH ) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is It the Right Time to Hold Labcorp in Your Portfolio? - Hims & Hers Health ( NYSE:HIMS ) , Labcorp Holdings ( NYSE:LH )
Laboratory Corporation of America Holdings LH, or Labcorp's, focused efforts in the high-growth areas position it for strong growth in the upcoming quarters. The company has an extensive set of acquisition opportunities in hospitals and local laboratories, which is also encouraging.
Is It the Right Time to Hold Labcorp ( LH ) in Your Portfolio?
Labcorp's (LH) concentrated development in high-growth areas and strategic partnerships appear encouraging.
Preeclampsia can be fatal for pregnant people and babies. New blood tests aim to show who's at risk
When you're expecting a baby, you hope nothing goes wrong. But at least one in 20 people who are pregnant develop a scary complication called preeclampsia, a high blood pressure disorder that kills worldwide every year. There was no way to know when it might strike - until now.
Quest Diagnostics ( DGX ) Gains From New M&As Amid Competition
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share gains driven by the competitive strength of its scale and innovative offerings.
Why Is OPKO Health ( OPK ) Up 12.8% Since Last Earnings Report?
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Laboratory Co. of America ( NYSE:LH ) Cut to "Hold" at StockNews.com
Laboratory Co. of America ( NYSE:LH - Get Free Report ) was downgraded by stock analysts at StockNews.com from a "buy" rating to a "hold" rating in a research note issued to investors on Tuesday.
Illumina drives genomic testing as standard of care in oncology through collaborative research presented at ASCO
Studies presented represent key focus areas, including building evidence for clinical utility of comprehensive genomic profiling; overcoming market access barriers, and progressing the whole-genome approach for MRD
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference
BURLINGTON, N.C., May 28, 2024 /PRNewswire/ -- Labcorp ( NYSE: LH ) , a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the 44th Annual William Blair Growth Stock Conference on ...
Laboratory Co. of America ( NYSE:LH ) Upgraded to "Buy" at StockNews.com
StockNews.com upgraded shares of Laboratory Co. of America ( NYSE:LH - Free Report ) from a hold rating to a buy rating in a research note released on Monday morning.
Why Labcorp ( LH ) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Labcorp ( LH ) to Assess Preeclampsia Risk With New Test
Labcorp's (LH) new first-trimester test is the latest addition to its dedication to improving women's health.
Fortrea Reports First Quarter 2024 Results - Fortrea Holdings ( NASDAQ:FTRE )
For the three months ended March 31, 2024, from continuing operations: GAAP and adjusted diluted earnings ( loss ) per share of $ ( 0.91 ) and $ ( 0.04 ) , respectively Book-to-bill ratio of 1.11x, resulting in >1.2x book-to-bill for the trailing nine months
Fortrea Reports First Quarter 2024 Results
For the three months ended March 31, 2024, from continuing operations: ...
Here's Why Investors Should Retain Labcorp ( LH ) Stock for Now
Investors are optimistic about Labcorp (LH), led by strategic acquisitions and strong expansion in the Biopharma Laboratory.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Integer Holdings ( ITGR ) Q1 Earnings Top Estimates, Margins Up
Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.
Labcorp ( LH ) Tops Q1 Earnings Estimates, Raises 2024 EPS View
Labcorp (LH) sets a strong foundation for the year ahead with its impressive performance in the first quarter of 2024.
Labcorp Announces 2024 First Quarter Results
• Results from Continuing Operations for first quarter 2024 versus last year: • Full-Year 2024 Guidance: Raised midpoint and narrowed range of adjusted EPS to to ; Free Cash Flow remains to • Year to date announced/completed five acquisitions that support our strategy
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss?
Here is a sneak peek into how the three major MedTech stocks, LH, EW and RMD, are expected to fare in their quarterly results slated to be released tomorrow.
5 Large-Cap Medical Stocks to Buy Ahead of Q1 Earnings
We have narrowed our search to five S&P 500 medical stocks that are poised to beat on first-quarter earnings results.These are: HCA, UHS, LH, EW, PODD.
Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight
The rise in demand for dental lasers is mainly driven by the growing occurrence of dental issues like bleeding or inflamed gums, tooth decay, and root infections. Furthermore, advancements in dental technology play a significant role in fostering market growth.
